Eledon Pharmaceuticals Inc. buy Guggenheim
Start price
28.01.25
/
50%
€4.54
Target price
28.01.26
€8.63
Performance (%)
-38.77%
Price
06.08.25
€2.96
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Eledon Pharmaceuticals Inc. is performing very badly with a performance of -38.77%. This prediction currently runs until 28.01.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eledon Pharmaceuticals Inc. | 7.813% | 7.813% |
| iShares Core DAX® | -0.933% | 0.936% |
| iShares Nasdaq 100 | -2.152% | 3.580% |
| iShares Nikkei 225® | 0.021% | 1.387% |
| iShares S&P 500 | -2.296% | 2.847% |
Comments by Guggenheim for this prediction
In the thread Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat